Second autologous stem cell transplant for multiply relapsed Hodgkin's disease

Bone Marrow Transplantation

Volumn 29, Issue 9, 2002, Pages 763-767

  Lin, T S ^a   Avalos, B R ^a   Penza, S L ^a   Marcucci, G ^a   Elder, P J ^a   Copelan, E A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Hodgkin's disease; Pneumonitis; Relapse; Second transplant

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; THIOTEPA;

ADULT; ARTICLE; BACTERIAL INFECTION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LEUKOCYTE COUNT; LUNG DISEASE; MALE; MANTLE FIELD RADIOTHERAPY; MEDICAL DECISION MAKING; MYCOSIS; PATIENT SELECTION; PRIORITY JOURNAL; THROMBOCYTE COUNT; TIME; TREATMENT OUTCOME; VEIN OCCLUSION; VIRUS INFECTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; KINETICS; MALE; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036269422     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703546     Document Type: Article

References (20)

1. The treatment of Hodgkin's disease
2. The management of Hodgkin's disease: Half a century of change
3. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long-term follow-up in 128 patients
4. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease: A single-center eight-year study of 155 patients
5. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
6. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: A prognostic model for treatment outcomes
7. Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease
8. Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
9. Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients
10. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience
11. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
12. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
13. Second autologous bone marrow transplantation in Hodgkin's disease
14. Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry
15. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease
16. Second transplants for leukaemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GVHD on continued remission
17. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse
18. Second HLA-identical sibling transplants for leukemia recurrence
19. Favorable prognosis after late relapse of Hodgkin's disease
20. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease